Omron’s AI unit hunts for rare diseases in data on 50m Japanese patients
Artificial intelligence
Company’s work aims to find enough participants for clinical trials for overlooked illnesses
JMDC employees discuss the use of medical data. (Photo by Yuta Maeda)
TOKYO — A healthcare data subsidiary of Japanese medical device maker Omron is unleashing artificial intelligence on a huge trove of patient data in hopes of finding rare-disease clusters large enough to help unlock new treatments.
